GaStroEsophageal effeCt of indobUfen Versus aspiRin in Patients Undergoing Dual antiplatElet Therapy

NCT04129008 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

88

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease
Gastroesophageal Reflux Disease

Interventions

DRUG: Indobufen and aspirin mimetic
DRUG: Aspirin and indobufen mimetic

Sponsor

Beijing Anzhen Hospital